Stefano Ferrara

563 total citations
10 papers, 297 citations indexed

About

Stefano Ferrara is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stefano Ferrara has authored 10 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stefano Ferrara's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Renal cell carcinoma treatment (3 papers). Stefano Ferrara is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Renal cell carcinoma treatment (3 papers). Stefano Ferrara collaborates with scholars based in United States, Australia and Spain. Stefano Ferrara's co-authors include David Goldstein, Josep Tabernero, Ramesh K. Ramanathan, Daniel D. Von Hoff, Werner Scheithauer, Brian Lu, Darryl Penenberg, Alfredo Romano, Sunil R. Hingorani and Vinod Ganju and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Stefano Ferrara

9 papers receiving 293 citations

Peers

Stefano Ferrara
Sebastian Cummins United Kingdom
Tom Crosby United Kingdom
Steffi Rombouts Netherlands
Marieke S. Walma Netherlands
Xiujiang Yang China
Matthew J. Iott United States
Felix Ho United States
Eva Jouve France
Jeremy L. Humphris Australia
Alexandra N. Willauer United States
Sebastian Cummins United Kingdom
Stefano Ferrara
Citations per year, relative to Stefano Ferrara Stefano Ferrara (= 1×) peers Sebastian Cummins

Countries citing papers authored by Stefano Ferrara

Since Specialization
Citations

This map shows the geographic impact of Stefano Ferrara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Ferrara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Ferrara more than expected).

Fields of papers citing papers by Stefano Ferrara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Ferrara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Ferrara. The network helps show where Stefano Ferrara may publish in the future.

Co-authorship network of co-authors of Stefano Ferrara

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Ferrara. A scholar is included among the top collaborators of Stefano Ferrara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Ferrara. Stefano Ferrara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tempero, Margaret A., Michele Reni, Hanno Riess, et al.. (2019). APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.. Journal of Clinical Oncology. 37(15_suppl). 4000–4000. 97 indexed citations
2.
Young, Rosemary, Paul N. Mainwaring, Philip Clingan, et al.. (2018). nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial. Asia-Pacific Journal of Clinical Oncology. 14(5). e325–e331. 4 indexed citations
3.
Caruso, Enrico, Stefano Ferrara, Paolo Ferruti, et al.. (2017). Enhanced photoinduced antibacterial activity of a BODIPY photosensitizer in the presence of polyamidoamines. Lasers in Medical Science. 33(6). 1401–1407. 16 indexed citations
4.
Tabernero, Josep, et al.. (2017). <em>nab</em>-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial. OncoTargets and Therapy. Volume 10. 591–596. 16 indexed citations
5.
Kunzmann, Volker, Ramesh K. Ramanathan, David Goldstein, et al.. (2016). Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine. Pancreas. 46(2). 203–208. 21 indexed citations
6.
7.
Tabernero, Josep, E. Gabriela Chiorean, Jeffrey R. Infante, et al.. (2015). Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer. The Oncologist. 20(2). 143–150. 110 indexed citations
8.
Kunzmann, Volker, Ramesh K. Ramanathan, David Goldstein, et al.. (2015). Tumor reduction in pancreatic versus metastatic sites in a randomized phase III study (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.. Journal of Clinical Oncology. 33(3_suppl). 382–382. 1 indexed citations
9.
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Cummins Breakdown of academic impact, for papers by Tom Crosby Breakdown of academic impact, for papers by Steffi Rombouts Breakdown of academic impact, for papers by Marieke S. Walma Breakdown of academic impact, for papers by Xiujiang Yang Breakdown of academic impact, for papers by Matthew J. Iott Breakdown of academic impact, for papers by Felix Ho Breakdown of academic impact, for papers by Eva Jouve Breakdown of academic impact, for papers by Jeremy L. Humphris Breakdown of academic impact, for papers by Alexandra N. Willauer
Rankless by CCL
2026